Rocket Lab (NASDAQ:RKLB) experienced a remarkable surge in its share price last week, climbing 27.5% to close Friday at $82.83. This rally added approximately $10.7 billion to the company's equity value, setting the stage for a highly anticipated second-quarter earnings report due Monday after the market closes.
The sharp increase in valuation comes as investors position themselves ahead of the earnings release, with the stock now trading at a significant premium relative to its contracted backlog. As of the end of March, Rocket Lab had $2.22 billion in contracted work yet to be fulfilled, but only 36% of that is expected to convert into revenue within the next year. The market's enthusiasm has pushed the equity value to roughly 4.8 times the size of that backlog, highlighting the magnitude of last week's revaluation.
Valuation and Market Metrics
At the close of trading on August 7, Rocket Lab's approximate equity value stood at $49.55 billion, up from $38.85 billion on July 31. This represents a one-week increase of $10.70 billion. The company's equity value-to-trailing-revenue multiple expanded from 57.2 times to 72.9 times, a jump of 15.7 turns, based on trailing revenue of $679.58 million and a share count of 598.18 million.
In extended-hours trading, the stock continued to show strength, with an initial quote at 04:04 EDT displaying $85.70, up 3.5% from Friday's close. However, liquidity during pre-market hours is typically thinner, so these early moves should be interpreted with caution.
Earnings Expectations
Wall Street analysts are projecting second-quarter revenue of $231.62 million, which would represent a 60.3% increase year-over-year and a 15.6% sequential rise. The consensus also calls for a per-share loss of $0.06. This revenue estimate aligns closely with the midpoint of Rocket Lab's own guidance, which ranged from $225 million to $240 million.
Margins remain a key focus, with the company guiding GAAP gross margin between 33% and 35%, three to five percentage points below the first-quarter level of 38.2%. The adjusted EBITDA loss is expected to be between $20 million and $26 million.
Operational Highlights
Last week brought significant operational developments. Rocket Lab secured a $397 million contract from the U.S. Space Force, which includes an option and is focused on the Neutron project's progress and contract schedule. The company also completed its 92nd Electron launch, deploying a satellite for iQPS, a subsidiary of QPS Holdings. This marked the 13th Electron mission of 2026 and the eighth for iQPS, which has secured ten additional exclusive launches on Electron through 2030.
CEO Peter Beck emphasized that Rocket Lab's integrated approach "uniquely position[s] us to deliver innovative solutions," underscoring the strategic importance of the Space Force contract. The deal ties part of the company's growth outlook to Neutron, whose inaugural launch is slated for later in 2026.
Analyst Sentiment and Price Targets
Wall Street remains largely optimistic, though price targets vary widely. According to MarketBeat, the consensus rating is "Moderate Buy," based on 16 buy ratings, five holds, and one sell. The average price target stands at $110.29, implying a potential upside of 33.2% from Friday's close. Notable recent ratings include a Neutral from Piper Sandler with a $83 target, an Overweight from Cantor Fitzgerald at $96, a Buy from Needham at $120, and a Buy from Roth Capital at $130.
Key Risks and What to Watch
Investors should be aware that contract values are recognized upon milestone achievements, not when awards are announced. The $397 million Space Force contract includes an option, and revenue timing could be affected if Neutron faces further delays. Given the stock's elevated multiple of 72.9 times trailing sales, any shortfall in earnings or guidance could trigger a sharp selloff.
Monday's earnings release, scheduled after the close, will be followed by a conference call at 5 p.m. EDT. Key items on investors' radar include revenue, GAAP margin, backlog details, and updates on the Neutron program. With launch activity remaining robust, the market's focus will be on how quickly the company can convert its backlog into revenue to justify its current valuation.
